Dawn R. Ainger, as a listed inventor on the '717 patent is a joint owner in and tothe '717 patent.13.
CE-HQ is an exclusive licensee of University of Iowa Research Foundation to itsrights in the '717 Patent and has the right to prosecute in its own name any infringement of the'717 patent, CE-HQ is also authorized to recover all claims for damages for past present andfuture infringement of the '717 patent.14.
CE-HQ is an exclusive licensee of Dawn R. Ainger to her rights in the '717 Patentand has the right to prosecute in its own name any infringement of the '717 patent, CE-HQ is alsoauthorized to recover all claims for damages for past present and future infringement of the '717patent.15.
UpToDate markets an "evidence-based clinical decision support resource" (the"UpToDate System") which is used "to help healthcare practitioners make the best decisions atthe point of care." Exhibit B (true and correct copies of pages from UpToDate’s websiteattached), p. 1.16.
According to UpToDate, answering questions at the point of care, during patientencounters, fundamentally "influences decisions that have an impact on patient safety and qualityof care." Exhibit C (true and correct copies of pages from Wolters Kluwer Health’s websiteattached), p. 4.17.
The UpToDate system includes information on a variety of medical topics. All of these topics "are written exclusively for UpToDate by renowned physicians who are experts intheir specialty." Exhibit B, pp. 2-8. In assembling the topics, "UpToDate has a systemic processfor identifying, reviewing and synthesizing the medical literature as it applies to a clinicalquestion." Exhibit B, pp. 9-10.